-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SV-102 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SV-102 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SV-102 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug...
-
Innovation Ranking
Innovation Ranking – Huizhou Desay SV Automotive Co.,Ltd.
Huizhou Desay SV Automotive Co Ltd (Desay SV) manufactures, distributes, research, and development of automotive parts and electronic products. The company product portfolio includes user interaction, in-vehicle infotainment systems, connectivity technologies, sensors and perception, localization, path planning, and decision-making, telematics service Platform, cyber security, and OTA among others. Desay SV operates research and development branches in Chengdu, Nanjing, Shanghai, Taipei, Shenzhen, and Guangzhou. The company operates in Japan, Germany, Mexico, the US, Russia, India, Sweden, Singapore, and Indonesia. Desay SV...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SV-101 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SV-101 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SV-101 in Non-Small Cell Lung Cancer Drug Details: SV-101 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bria-IMT in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bria-IMT in Triple-Negative Breast Cancer (TNBC) Drug Details: Bria-IMT...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bria-IMT in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bria-IMT in Metastatic Breast Cancer Drug Details: Bria-IMT (BriaVax) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bria-IMT in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bria-IMT...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bria-IMT in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bria-IMT in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bria-IMT...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rifamycin Sodium CR in Hepatic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifamycin Sodium CR in Hepatic Encephalopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifamycin Sodium CR in Hepatic Encephalopathy Drug Details: Rifamycin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rifamycin Sodium CR in Bacterial Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifamycin Sodium CR in Bacterial Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifamycin Sodium CR in Bacterial Infections Drug Details: Rifamycin...